Despite negative endpoints, researchers remain committed to lifestyle modifications

Despite two negative NHLBI-sponsored trials presented at the AHA last November, researchers remain convinced that lifestyle modification is worthwhile, according to  a feature news story in JAMA by Mike Mitka. Both FIT Heart and HF-ACTION failed to reach their primary endpoint, but the researchers, Lori Mosca of Columbia and Chris O’Connor of Duke, make a strong case for the continued utility of the interventions tested in their trials.